
COCO SILVIA
- U08, Floor: 2, Room: 2027
- U08, Floor: 2, Room: 2020
Publications
Meanti, R., Bresciani, E., Rizzi, L., Coco, S., Zambelli, V., Dimitroulas, A., et al. (2023). Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis. CURRENT NEUROPHARMACOLOGY, 21(12), 2376-2394 [10.2174/1570159X20666220915103613]. Detail
Meanti, R., Licata, M., Rizzi, L., Bresciani, E., Molteni, L., Coco, S., et al. (2023). Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(2) [10.3390/ijms24020993]. Detail
Rizzi, L., Turati, M., Bresciani, E., Anghilieri, F., Meanti, R., Molteni, L., et al. (2022). Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears. BIOMEDICINES, 10(11) [10.3390/biomedicines10112909]. Detail
Zambelli, V., Rizzi, L., Delvecchio, P., Bresciani, E., Rezoagli, E., Molteni, L., et al. (2021). Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury. DRUG TARGET INSIGHTS, 15(1), 26-33 [10.33393/dti.2021.2347]. Detail
Meanti, R., Rizzi, L., Bresciani, E., Molteni, L., Locatelli, V., Coco, S., et al. (2021). Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity. PHARMACEUTICALS, 14(5) [10.3390/ph14050444]. Detail
Research projects
Awards
Scientific fellowships
- Socio effettivo o corrispondente - Forum of Italian Researchers on Mesenchymal Stromal Stem Cells (FIRST), 2016
- Socio effettivo o corrispondente - Federation European Neuroscience Societies (FENS), 2014
- Socio effettivo o corrispondente - Milan Center for Neuroscience (NEUROMI), 2014
- Socio effettivo o corrispondente - Società Italiana di Neuroscienze, 2011